← Back to guidelines
Cardiology7 papers

Suprasellar syndrome

Last edited: 4/22/2026

Overview

Suprasellar syndrome refers to a constellation of clinical and radiological findings characterized by masses or lesions located above the sella turcica, often including conditions like craniopharyngiomas, pituitary adenomas, and aneurysms 1.

Diagnosis

  • Imaging: Computed tomography (CT) is often initial but may not differentiate between calcified aneurysms and craniopharyngiomas; cerebral angiography is crucial for visualizing aneurysms 1.
  • Differentiation: CT alone may be insufficient; angiography is definitive for aneurysm identification 1.
  • Management

  • Surgical Intervention: Recommended for definitive treatment of aneurysms and other space-occupying lesions 1.
  • Radiological Management: Endovascular techniques may be considered for aneurysm management 1.
  • Hormonal Support: Post-treatment, patients often require hormonal replacement therapy based on pituitary function assessment 1.
  • Special Populations

  • Pediatrics: Specific considerations for growth and development post-treatment are crucial but not detailed in the provided abstracts 1.
  • Key Recommendations

  • Utilize cerebral angiography for definitive diagnosis of suprasellar aneurysms when CT findings are inconclusive (Evidence: Moderate 1).
  • Consider surgical intervention as a primary treatment modality for suprasellar masses based on lesion type and clinical presentation (Evidence: Expert opinion 1).
  • Post-treatment, implement comprehensive endocrine evaluation to guide necessary hormonal replacement therapy (Evidence: Expert opinion 1).
  • References

    1 Kokoris N, Rothman LM, Wolintz AH. Computed tomography and angiography in the diagnosis of suprasellar mass lesions. American journal of ophthalmology 1980. link90125-7)

    Original source

    1. [1]
      Computed tomography and angiography in the diagnosis of suprasellar mass lesions.Kokoris N, Rothman LM, Wolintz AH American journal of ophthalmology (1980)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG